GLOBAL PHARMA SOLUTIONS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GLOBAL PHARMA SOLUTIONS
Largest movements
- Cash +€42,351
up €42,351 (+384,311%), from €11 to €42,362
mainly Net result for the year (+€87,596) and Receivables within one year (+€27,072)
- Receivables within one year -€27,072
down €27,072 (-90.7%), from €29,846 to €2,774
of which Trade receivables: -€29,071
- Tangible fixed assets +€20,243
new in 2025: €20,243
- Profit (loss) carried forward +€75,115
up €75,115, from -€75,115 to €0
- Other debts -€34,262
down €34,262 (-88.6%), from €38,665 to €4,403
- Tax, wage and social debts -€26,194
down €26,194 (-71.2%), from €36,815 to €10,621
of which Taxes: -€23,894
- Debts after one year +€12,884
new in 2025: €12,884
- Reserves +€12,481
up €12,481 (+1,787%), from €699 to €13,179
- Gross operating margin +€97,533
up €97,533 (+309%), from €31,516 to €129,049
- Taxes +€18,302
up €18,302 (+176%), from €10,396 to €28,698
- Other operating charges +€3,879
up €3,879 (+161%), from €2,405 to €6,284
- Depreciation +€2,865
new in 2025: €2,865
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €31,132 | €66,770 | +€35,638 | +114% |
| Fixed assets | 21/28 | €170 | €20,413 | +€20,243 | +11,908% |
| Tangible fixed assets | 22/27 | - | €20,243 | +€20,243 | |
| Furniture and vehicles | 24 | - | €20,243 | +€20,243 | |
| Financial fixed assets | 28 | €170 | €170 | = | 0.0% |
| Current assets | 29/58 | €30,962 | €46,357 | +€15,395 | +49.7% |
| Amounts receivable within one year | 40/41 | €29,846 | €2,774 | -€27,072 | -90.7% |
| Trade receivables | 40 | €29,846 | €775 | -€29,071 | -97.4% |
| Other amounts receivable | 41 | €0 | €1,999 | +€1,999 | |
| Cash at bank and in hand | 54/58 | €11 | €42,362 | +€42,351 | +384,311% |
| Deferred charges and accrued income | 490/1 | €1,105 | €1,221 | +€116 | +10.5% |
| Total equity and liabilities | 10/49 | €31,132 | €66,770 | +€35,638 | +114% |
| Equity | 10/15 | -€55,817 | €31,779 | +€87,596 | |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €699 | €13,179 | +€12,481 | +1,787% |
| Distributable reserves | 133 | €699 | €13,179 | +€12,481 | +1,787% |
| Profit (loss) carried forward | 14 | -€75,115 | €0 | +€75,115 | |
| Amounts payable | 17/49 | €86,948 | €34,990 | -€51,958 | -59.8% |
| Amounts payable after more than one year | 17 | - | €12,884 | +€12,884 | |
| Financial debts | 170/4 | - | €12,884 | +€12,884 | |
| Amounts payable within one year | 42/48 | €86,253 | €21,411 | -€64,842 | -75.2% |
| Current portion of amounts payable after more than one year | 42 | - | €4,793 | +€4,793 | |
| Trade debts | 44 | €10,774 | €1,595 | -€9,179 | -85.2% |
| Suppliers | 440/4 | €10,774 | €1,595 | -€9,179 | -85.2% |
| Taxes, remuneration and social security | 45 | €36,815 | €10,621 | -€26,194 | -71.2% |
| Taxes | 450/3 | €34,515 | €10,621 | -€23,894 | -69.2% |
| Remuneration and social security | 454/9 | €2,300 | €0 | -€2,300 | -100% |
| Other amounts payable | 47/48 | €38,665 | €4,403 | -€34,262 | -88.6% |
| Accrued charges and deferred income | 492/3 | €695 | €695 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €2,865 | +€2,865 | |
| Other operating charges | 640/8 | €2,405 | €6,284 | +€3,879 | +161% |
| Gross operating margin | 9900 | €31,516 | €129,049 | +€97,533 | +309% |
| Operating profit (loss) | 9901 | €29,111 | €119,900 | +€90,790 | +312% |
| Financial income | 75/76B | €0 | €32 | +€32 | |
| Recurring financial income | 75 | €0 | €32 | +€32 | |
| Financial charges | 65/66B | €2,718 | €3,637 | +€919 | +33.8% |
| Recurring financial charges | 65 | €2,718 | €3,637 | +€919 | +33.8% |
| Profit (loss) for the period before taxes | 9903 | €26,392 | €116,294 | +€89,902 | +341% |
| Income taxes | 67/77 | €10,396 | €28,698 | +€18,302 | +176% |
| Profit (loss) for the period | 9904 | €15,996 | €87,596 | +€71,600 | +448% |
| Profit (loss) for the period to be appropriated | 9905 | €15,996 | €87,596 | +€71,600 | +448% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.